Clinical Trials Browser

Terminated × Neoplasm, Residual × blinatumomab × Clear all

NCT04506086 2025-05-18

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

Phase 4 Terminated

10 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04785547 2024-01-16

ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04044560 2022-02-21

OZM-097

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma